About Colleen Delaney
Form D filings for Deverra Therapeutics from 2020 to 2023 list Colleen Delaney as executive officer.
Colleen Delaney first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Colleen Delaney in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Colleen Delaney works with at each company, as listed on that company's latest Form D.
Deverra Therapeutics, Inc. · Form D, Sep 18, 2023
MY
Michael Yurkowsky
Chief Executive Officer